| Gregory J Ensing, MD | |
|
1500 East Medical Center Dr, 11th Floor Cs Mott Childrens Hospital Rm 661, Ann Arbor, MI 48109-5204 | |
| (734) 764-5176 | |
| Not Available |
| Full Name | Gregory J Ensing |
|---|---|
| Gender | Male |
| Speciality | Pediatric Medicine |
| Experience | 42 Years |
| Location | 1500 East Medical Center Dr, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306856927 | NPI | - | NPPES |
| 3490907 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 4301072519 (Michigan) | Secondary |
| 2080P0202X | Pediatrics - Pediatric Cardiology | 4301072519 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Michigan Health System | Ann arbor, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regents Of The University Of Michigan | 3779496856 | 2953 |
News Archive
A new project spearheaded by a Saint Louis University cardiac surgeon is aiming to connect an underserved population with health care services in the St. Louis region.
Obesity alone may no longer be linked to a high risk of death in women, according to research published in the Nov. 2010 Medicine & Science in Sports & Exercise, the official journal of the American College of Sports Medicine. Researchers now suggest cardiovascular fitness level, not just a woman's size, may actually be the key predictor of health level and overall risk for death.
Congenital syphilis is a major preventable public health problem in many developing countries, frequently causing stillbirths or neonatal death and disabling children who survive.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the European Patent Office (EPO) has issued a notification of intent to grant for a patent in the Kreutzer-Limmer III patent series (EP Application No 02702247.4). This patent series stems from the pioneering RNAi research performed by scientists at Ribopharma AG, which was acquired by Alnylam in 2003.
› Verified 1 days ago
| Entity Name | Regents Of The University Of Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205868353 PECOS PAC ID: 3779496856 Enrollment ID: O20031106000325 |
News Archive
A new project spearheaded by a Saint Louis University cardiac surgeon is aiming to connect an underserved population with health care services in the St. Louis region.
Obesity alone may no longer be linked to a high risk of death in women, according to research published in the Nov. 2010 Medicine & Science in Sports & Exercise, the official journal of the American College of Sports Medicine. Researchers now suggest cardiovascular fitness level, not just a woman's size, may actually be the key predictor of health level and overall risk for death.
Congenital syphilis is a major preventable public health problem in many developing countries, frequently causing stillbirths or neonatal death and disabling children who survive.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the European Patent Office (EPO) has issued a notification of intent to grant for a patent in the Kreutzer-Limmer III patent series (EP Application No 02702247.4). This patent series stems from the pioneering RNAi research performed by scientists at Ribopharma AG, which was acquired by Alnylam in 2003.
› Verified 1 days ago
| Entity Name | Hurley Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982630844 PECOS PAC ID: 2961308481 Enrollment ID: O20031208000375 |
News Archive
A new project spearheaded by a Saint Louis University cardiac surgeon is aiming to connect an underserved population with health care services in the St. Louis region.
Obesity alone may no longer be linked to a high risk of death in women, according to research published in the Nov. 2010 Medicine & Science in Sports & Exercise, the official journal of the American College of Sports Medicine. Researchers now suggest cardiovascular fitness level, not just a woman's size, may actually be the key predictor of health level and overall risk for death.
Congenital syphilis is a major preventable public health problem in many developing countries, frequently causing stillbirths or neonatal death and disabling children who survive.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the European Patent Office (EPO) has issued a notification of intent to grant for a patent in the Kreutzer-Limmer III patent series (EP Application No 02702247.4). This patent series stems from the pioneering RNAi research performed by scientists at Ribopharma AG, which was acquired by Alnylam in 2003.
› Verified 1 days ago
| Entity Name | Dlp Marquette Physician Practices Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487902995 PECOS PAC ID: 9931359601 Enrollment ID: O20121016000312 |
News Archive
A new project spearheaded by a Saint Louis University cardiac surgeon is aiming to connect an underserved population with health care services in the St. Louis region.
Obesity alone may no longer be linked to a high risk of death in women, according to research published in the Nov. 2010 Medicine & Science in Sports & Exercise, the official journal of the American College of Sports Medicine. Researchers now suggest cardiovascular fitness level, not just a woman's size, may actually be the key predictor of health level and overall risk for death.
Congenital syphilis is a major preventable public health problem in many developing countries, frequently causing stillbirths or neonatal death and disabling children who survive.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the European Patent Office (EPO) has issued a notification of intent to grant for a patent in the Kreutzer-Limmer III patent series (EP Application No 02702247.4). This patent series stems from the pioneering RNAi research performed by scientists at Ribopharma AG, which was acquired by Alnylam in 2003.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory J Ensing, MD 3621 S State St, 700 Kms Place, Ann Arbor, MI 48108 Ph: (734) 936-2047 | Gregory J Ensing, MD 1500 East Medical Center Dr, 11th Floor Cs Mott Childrens Hospital Rm 661, Ann Arbor, MI 48109-5204 Ph: (734) 764-5176 |
News Archive
A new project spearheaded by a Saint Louis University cardiac surgeon is aiming to connect an underserved population with health care services in the St. Louis region.
Obesity alone may no longer be linked to a high risk of death in women, according to research published in the Nov. 2010 Medicine & Science in Sports & Exercise, the official journal of the American College of Sports Medicine. Researchers now suggest cardiovascular fitness level, not just a woman's size, may actually be the key predictor of health level and overall risk for death.
Congenital syphilis is a major preventable public health problem in many developing countries, frequently causing stillbirths or neonatal death and disabling children who survive.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the European Patent Office (EPO) has issued a notification of intent to grant for a patent in the Kreutzer-Limmer III patent series (EP Application No 02702247.4). This patent series stems from the pioneering RNAi research performed by scientists at Ribopharma AG, which was acquired by Alnylam in 2003.
› Verified 1 days ago
Dr. Michael Edmund Watson, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Joanna Van Beek, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1500 E Medical Center Dr, D3238 Mpb Spc 5718, Ann Arbor, MI 48109 Phone: 734-763-5589 Fax: 734-763-4208 | |
Ashleigh Grund El Sakr, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4900 Jackson Rd Ste A, Ann Arbor, MI 48103 Phone: 734-998-7380 | |
Jennifer Rose Blase, MD, PH.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Vishvanie Bernadene Stoody, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Maysa Hamade, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Dr. Alejandro Velez Lopez, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 |